Related content

Telomere length of in vivo expanded CD4⁺CD25⁺ regulatory T-cells is preserved in cancer patients

By Wolf Dominik   Rumpold Holger   Koppelstätter Christian   Gastl Guenther   Steurer Michael   Mayer Gert   Gunsilius Eberhard   Tilg Herbert   Wolf Anna  

Cancer Immunology, Immunotherapy, Vol. 55, Iss. 10, 2006-10 ,pp. : 1198-1208

Springer Publishing Company

Access to resources Recommend Favorite

Breast cancer cell CD200 expression regulates immune response to EMT6 tumor cells in mice

By Gorczynski Reginald   Chen Zhiqi   Diao Jun   Khatri Ismat   Wong Karrie   Yu Kai   Behnke Julia  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 405-415

Springer Publishing Company

Access to resources Recommend Favorite

CD4+ T cells inhibit the neu-specific CD8+ T-cell exhaustion during the priming phase of immune responses against breast cancer

By Kmieciak Maciej  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 385-394

Springer Publishing Company

Access to resources Recommend Favorite

Increased expression of herpesvirus entry mediator in 1,25dihydroxyvitamin D3treated mouse bone marrowderived dendritic cells promotes the generation of CD4+CD25+Foxp3+ regulatory T cells

By        

Molecular Medicine Reports, Vol. 9, Iss. 3, 2014-01 ,pp. : 813-818

Spandidos Publications

Access to resources Recommend Favorite

CD4⁺ T-cell recognition of human 5T4 oncofoetal antigen: implications for initial depletion of CD25⁺ T cells

By Elkord Eyad   Burt Deborah   Drijfhout Jan   Hawkins Robert   Stern Peter  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 6, 2008-06 ,pp. : 833-847

Springer Publishing Company

Access to resources Recommend Favorite